Trial NCT03696212

View at ClinicalTrials.gov 
Org. Study IDs: ARYS-002
Secondary IDs: KEYNOTE-888

Last trial update was posted on 2021-02-21

MeSH Interventions

Pembrolizumab

MeSH Conditions

Adenocarcinoma Adenocarcinoma of Lung Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer Adenocarcinoma

Stopping Reasons

Based on the totality of the generated combined safety and efficacy data in the interim period, the company decided to terminate the combination study in NSCLC patients. There are no subjects on study drug at this time or in the EOT Follow-up period.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID